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ABSTRACT The murine major histocompatibility com-
plex encodes H-2K and H-2D transplantation antigens and
other class I-like proteins called Qa and Tla molecules; the
functions of the Qa/Tla molecules are not known. That they
may participate in embryonic cell-cell interactions and/or
play a role in immune responses against tumors has been
speculated. We have studied two murine embryonal carcinoma
tumors, 402AX and PCC4, that are rejected in Wvio immuno-
logically, although they do not express H-2K or H-2D antigens.
Transplantation studies with these cells suggest that rejection
is mediated by class-I-like major hstocompatibility complex
antigens. As a first step in evaluating Qa/Tla function(s), we
have characterized expression of class I-like genes and proteins
in 402AX and PCC4 cells. Northern (RNA) blot hybridizations,
polymerase chain reaction studies, and cDNA cloning experi-
ments demonstrate that EC lines tranribe genes allelic to the
Tla region gene "37", Qa-2 region gene "Q7", and another,
previously uncharacterized, class I-like gene. Immunoprecip-
itation studies show that the embryonal carcinoma tumor cells
contain low levels of .82-microglobulin expressed in association
with non-H-2K, non-H-2D class I-like proteins.
The murine major histocompatibility complex (MHC) en-
codes cell-surface glycoproteins involved in immune-
mediated recognition of foreign and self antigens. These
molecules include the well-characterized and highly poly-
morphic class I transplantation antigens. The MHC also
encodes the less polymorphic Qa and Tla class I antigens.
Although these molecules are similar in structure to the class
I antigens and associate with 832-microglobulin (132m), their
function is unknown. Because the H-2, Qa, and Tla antigens
are differentially expressed during early development (1, 2),
it has been hypothesized that they participate in embryonic
cell-cell interactions. This hypothesis is supported by the
observation that the gene encoding the Qa-2 antigen may
determine the rate of cleavage of cells in the preimplantation
embryo (3). Another hypothesis states that Qa and/or Tla
antigens may serve as restriction elements recognized by the
subset ofT lymphocytes expressing the T-cell receptor 'y- and
S-chain complex (4-6). Other studies (7-12) lead to the
speculation that class I-like antigens may function in presen-
tation of tumor antigens to T lymphocytes. This may be
particularly valid for tumor antigens of embryonic origin that
are not expressed during the T-cell tolerance induction stage
but reoccur later in life on malignant cells. Nonpolymorphic
Qa/Tla antigens could have, hypothetically, evolved to serve
as their restriction elements.
We are using murine teratocarcinomas as a model system
in which to study the function ofQa/Tla class I-like antigens.
These tumors include malignant, undifferentiated embryonal
carcinoma (EC) stem cells that do not express serologically
detectable H-2K and H-2D antigens. Transplantation and
cellular immunity data suggest, however, that EC cells ex-
press other class I-like molecules that may function as
restriction elements and/or transplantation antigens in anti-
tumor immunity (7-9). Because of their developmental pluri-
potency and ability to differentiate in vitro, EC cells may also
be an experimental system in which to study the role of
classical (H-2K and H-2D) and nonclassical (Qa and Tla)
class I antigens in differentiation and development.
In the present studies we have characterized the expres-
sion of class I-like proteins and H-2 homologous transcripts
in two different EC cell lines. We find that both EC cell lines
express class I-like molecules and transcribe Qa and/or Tla
genes. These results are discussed in the context of the
differences between H-2K, H-2D, and Qa/Tla expression.
MATERIALS AND METHODS
Materials. Mice were purchased from The Jackson Labo-
ratory. The 402AX cell line was maintained as described (13).
The PCC4 cell line was grown in minimal essential medium/
10o calf serum/1% L-glutamine (GIBCO) under sparse cul-
ture conditions (< approximately 1 x 103 cells per ml) to
maintain them in their undifferentiated state. Monoclonal
antibodies (mAbs) were prepared as described (14).
Immunoprecipitations. Cells were labeled with [35S]methi-
onine, and immunoprecipitations were performed as de-
scribed (15).
cDNA Libraries. cDNA libraries were prepared as de-
scribed (16-18) with modifications suggested by H. Cher-
outre (University of California, Los Angeles). Total RNA
was isolated from 109 402AX and PCC4 cells (19). Poly(A)+
RNA was prepared on Hybond-mAP paper as recommended
by the manufacturer (Amersham). cDNA was synthesized
from 3 pg of poly(A)+ RNA and size selected on an agarose
A1.5 column (0.5 x 10 cm). Largest cDNAs [>1.5 kilobases
(kb)] were ligated into the EcoRI site of AgtlO. Recombinant
phage were packaged and plated without amplification.
DNA Probes and Library Screening. The AC-14 probe
contains a 439-base Alu I fragment of nucleotides 2540-2979
of the H-2Dd gene cloned into the Sma I site of ml3mp8
vector (20); pH2IIa was described (21).
cDNA libraries were screened with a BamHI-HindIII
AC-14 fiagment isolated from ml3mp8 vector and rescreened
with pH2IIa.
DNA Sequencing. DNA sequencing was performed by the
dideoxy chain-termination method (22).
Abbreviations: EC, embryonal carcinoma; MHC, major histocom-
patibility complex; #32m, 82-microglobulin; mAb, monoclonal anti-
body; TM, transmembrane; PCR, polymerase chain reaction.
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Northern (RNA) Blot Analysis. Total RNA was isolated
(23), electrophoresed, blotted, and hybridized with class I or
actin probes. Class I pH2IIa-EH probe was constructed by
Elly Holthuizen (California Institute of Technology). This
probe contains a 276-base-pair (bp) Pst I-Sac I fragment of
pH2IIa a3 coding region cloned into Bluescript KS-2 vector.
Actin probe was constructed by subcloning a -900-bp Pst I
fragment of mouse a-skeletal actin cDNA into Bluescript
vector. The actin cDNA was cloned by S. B. Sharp (Cali-
fornia Institute of Technology) from a library constructed by
R. J. LaPolla and N. Davidson (California Institute of Tech-
nology). Hybridizations were at 370C in 5 x SSC (1x SSC is
0.15 M sodium chloride/0.015 M sodium citrate, pH 7) for 12-
18 hr. Filters were washed three times in 0.1% SDS with 2x
SSC, lx SSC, and 0.2x SSC at 650C.
Polymerase Chain Reaction (PCR). Two micrograms of
total RNA from cell lines and spleen cells (23) was converted
to cDNA using an Amersham cDNA synthesis kit. PCR
reactions (35 cycles) were done as in ref. 24 by using as
primers oligonucleotide TTGCCCACTTGCTTCAGCTGC-
TGGTCAG from exon 1 and oligonucleotide CTTCTGAG-
GCCAGTGAGAGGTCTG from exon 7 of the "37" gene.
Amplification products were hybridized for 16 hr at 370C in
6x SSC/1% SDS/denatured salmon sperm DNA at 100
,ug/ml/0.5% nonfat milk/10%o (wt/vol) dextran sulfate con-
taining a "37" gene-specific transmembrane probe (CCTAT-
GTGTCTCCTCC). The specificity of the probe was verified
by hybridization with a panel of BALB/c class I genes.
Membranes were washed in hybridization fluid without probe
at 450C for 15 min, in 0.1 x SSC/1% SDS at room temperature
for 15 min, and in 3.2 M tetramethylammonium chloride at
500C for 10 min.
RESULTS
EC Cells Express ,B2m-Associated Class I-Like Proteins. In
the present study we have analyzed two independently
isolated EC cell lines. The 402AX line was originally derived
from a primary spontaneous testicular teratocarcinoma of a
129/Sv (H-2b, Tlk) mouse (25) and has been adapted to cell
culture. This cell line does not express classical H-2K or
H-2D antigens and does not differentiate in vitro, even in the
presence of differentiating agents. Immune rejection of
402AX cells involves the induction of tumor antigens sero-
logically detected by H-2K and H-2D antibodies (14). In vitro
studies suggest that other class I-like molecules also function
in T-cell mediated recognition of 402AX cells (7).
PCC4 is a culture-adapted cell line derived from the 129/Sv
strain OTT6050 teratocarcinoma (26). Under low-density
culture conditions PCC4 does not differentiate and does not
express H-2K or H-2D antigens. When cultured at higher
densities or upon treatment with differentiation inducers,
PCC4 differentiates morphologically and biochemically and
expresses H-2K and H-2D antigens (27). The PCC4 line has
not been extensively studied in vivo, but growth of its sister
clone PCC3, derived from the same parental tumor, has been
analyzed (8). Rejection of the PCC3 tumor occurs in the
absence of serologically detectable H-2K and H-2D expres-
sion. Transplantation analyses suggest, however, that the
rejected PCC3 cells express antigens, which at the T-cell
epitope level, are closely related to H-2K and H-2D antigens.
To investigate whether EC cells express biochemically
detectable class I-like molecules, we have carried out immu-
noprecipitations on whole-cell lysates. We reasoned that EC
class I-like molecules may be encoded by Qa and/or Tla
genes. Available antibodies, however, only detect the gene
products of a very few of the -35 known Qa and Tla genes.
Because most class-I antigens are noncovalently associated
with the highly conserved p2m chain, we used a rabbit
anti-mouse-,f2m antiserum to immunoprecipitate 402AX and
PCC4 class I-like molecules. This strategy has been used
previously to precipitate and identify the nonclassical Q4
gene product (28, 29).
Two products are immunoprecipitated with the anti-/32m
antiserum from 402AX and PCC4 extracts (Fig. 1, lanes e and
i): a <14-kDa protein that comigrates with 129/J splenocyte
,82m (lane a) and 44- to 48-kDa proteins that migrate within
the molecular mass range predicted for class I polypeptides.
The anti-H-2Kb (208-4) and anti-H-2Db (28-14-8) mAbs
immunoprecipitate H-2K and H-2D antigens (lanes b and c)
from control 129/J splenocytes but are not reactive with
402AX and PCC4 cells (lanes f, g, j, and k). Negative control
anti-H-2Kk antibodies (11-4-1) do not react specifically with
any of the cell extracts (lanes d, h, and 1). The faint band of
=43 kDa in the 11-4-1 lanes corresponds in molecular mass
to actin, and is also seen in control bovine serum albumin-
treated lysates (data not shown). Because it has been previ-
ously reported that other EC cells do not transcribe 82m
genes (30, 31), we determined the level of 82m polypeptide
expression.
That H-2Db antigen can be expressed on the cell surface
without f82m has been shown (32). Therefore, 402AX cells
were transfected with the H-2Db gene fused to a Moloney
murine leukemia virus promoter (33), and the transfectant
clones positive with anti-H-2Db 28-14-8 mAb were biosyn-
thetically labeled and immunoprecipitated with 28-14-8
mAbs. High levels of H-2Db heavy chains in these transfec-
tants coprecipitated with trace amounts of ,B2m (data not
shown). In contrast, H-2Db antigens from activated 129/J
splenocytes precipitated with high levels of 82m chains (Fig.
1, lane c). Quantitative densitometry tracings of the two
autoradiographs indicate that the level off2m coprecipitated
with H-2Db antigen in 402AX transfectants is < =6% of the
,B2m coprecipitated with H-2Db antigens in 129/J splenocytes
(data not shown).
EC cells, therefore, express very low levels of ,B2m avail-
able for association with H-2 class I heavy chains. The 832m
proteins found in 402AX and PCC4 cells are associated with
non-H-2 class I-like polypeptides.
EC Cells Express MHC Class I Transcripts. Earlier studies
demonstrated that EC cells do not transcribe mature H-2
mRNAs (30, 31). These experiments relied on Northern
(RNA) analyses of EC RNA with H-2 class I probes and may
not have been sensitive enough to detect very low levels of
heterogeneous species of class I-like transcripts, especially if
129 spleen
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FIG. 1. Immunoprecipitations of MHC class I antigens from
129/J, 402AX, and PCC4 cells. Cell extracts containing approxi-
mately equal radioactivity were immunoprecipitated with each an-
tibody. 129/J Con A-stimulated blast (lanes a-d), 402AX (lanes e-h),
and PCC4 (lanes i-l) cells were immunoprecipitated with a rabbit
anti-mouse-p2m polyclonal antibody (fi2m; lanes a, e, and i), 20-8-4
mAb (anti-kb; lanes b, f, andj), 28-14-8 mAb (anti-Db; lanes c, g, and
k), or 11-4-1 mAb (anti-Kk; lanes d, h, and 1). Molecular mass
markers are bovine serum albumin (66 kDa), ovalbumin (43 kDa),
carbonic anhydrase (31 kDa), soybean trypsin inhibitor (21 kDa), and
lysozyme (14 kDa).
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these transcripts had low homology to the probes. Because
the size, nucleotide sequence, and relative abundance ofeach
of the Qa and Tla transcripts are not known, we have sought
to identify class I-like genes expressed in EC cells by three
methods.
Northern analysis of EC transcripts was performed using
as a probe pH2IIa EH, which is homologous to the conserved
a3 coding region of an unidentified class I-like gene and
hybridizes with all known BALB/c Qa and Tla genes as well
as with H-2Kd and H-2Dd genes. PCC4 and 402AX cells
express low but detectable levels of mature 41.7-kb class I
mRNAs (Fig. 2A). Densitometry quantitations of the EC
class I RNA bands and control actin RNA bands (see Fig. 2B)
indicate that PCC4 cells express =2% and 402AX cells
express -7% of the class I RNA expressed in C57BL/6
spleen cells.
To identify the class I RNAs present in EC cells, 402AX
and PCC4 cDNA expression libraries were prepared. Be-
cause immunoprecipitation data demonstrate that 402AX and
PCC4 cells express class I-like molecules that associate with
f32m, we screened the libraries with the AC-14 and pH2IIa
probes derived from the fourth exon of H-2 genes. The
screening yielded 2 positive plaques of8.5 x 105 total plaques
in the 402AX library and 136 positive plaques of 1.8 x 106
total plaques in the PCC4 library. DNAs from positive clones
were digested with EcoRI and sized by Southern blotting.
The positive clones fell into four classes: 402AX 2.4-kb,
PCC4 1.5-kb, PCC4 2.5-kb, and PCC4 3.0-kb clones. Within
a given group all cDNA inserts gave identical restriction
enzyme patterns when tested with Pvu II, Pst I, Rsa I,
HindIII, Xba I, and Xho I. The clones within each group also
hybridized with the same probes when analyzed with class I
gene-specific DNA fragments and oligonucleotides (data not
shown). A representative clone from each group was partially
sequenced and compared with known class I genes ofBALB/
c (Tiac) and C57BL/10 (Tiab) mice. Fig. 3 shows the sequenc-
ing strategy and aligns the four cDNA clones with the H-2
genes most homologous with them. All of the clones differ
from classical H-2 genes and contain regions, which in
classical H-2 transcripts, correspond to introns.
The 402AX and two of the PCC4 cDNA clones correspond
to known Qa- or Tla-region genes. The PCC4 1.5-kb clone
(Fig. 3A) is almost identical in the sequenced regions to the
Qa-2 region gene, Q7 (21, 36). The only variant nucleotide
between PCC4 1.5-kb clone and BALB/c Q7 sequence is
B
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FIG. 2. Northern analyses ofMHC class-I mRNA in EC cells. (A)
Detection of class I mRNAs. Approximately 20-40 ,ug of EC RNA
and -0.2 ,tg ofC57BL/6 spleen RNA was loaded per lane. Northern
hybridizations were done by using pH2IIaEH as a class I-exon
4-specific probe. All hybridizing bands have the same apparent
mobility relative to 18S and 28S rRNA. The visible difference in class
I band migration between EC and spleen lanes is caused by the
"100-fold difference in quantities of RNAs loaded. (B) Quantitation
of class I RNAs. Two identical nylon filters carrying blotted 402AX,
PCC4, and C57BL/6 spleen RNAs were hybridized with labeled
pH2IIa EH and actin probes and autoradiographed. The bands were
scanned by densitometer, and the level of class I mRNA was
estimated relative to the level of actin mRNA.
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FIG. 3. Sequencing strategy and comparison of402AX and PCC4
cDNA clones to knownMHC class I genes. UT, untranslated region.
(A) Comparison of PCC4 1.5-kb clone to BALB/c Q7d gene (ref. 21;
Q7d corrected GenBank sequence entered by D.N.). Dots under the
third intron and fourth exon correspond to positions 3923 and 4085,
where the PCC4 1.5-kb clone is adenine and cytosine as is Q7d,
whereas the Q7b allele is guanine and thymine. X under the fourth
intron denotes the only polymorphism between the PCC4G1.5-kb
clone and Q7d. It is an adenine at position 4246 instead of the guanine
found in the published Q7d sequence. Numbering is according to the
corrected GenBank Q7d (27.1) sequence. (B) Comparison of PCC4
2.5-kb and 402AX 2.4-kb clones to the Tla region "37" gene (34).
PCC4 2.5-kb and 402AX 2.4-kb sequences are identical with the
"37" gene sequence, except for three bases 5' to the ATG codon (see
Fig. 4) within the first exon (marked with X). The PCC4 2.5-kb clone
extends four bases beyond the 402AX 2.4-kb clone at the 3' end. (C)
Comparison ofPCC4 3.0-kb clone to Kdgene (35). PCC4 3.0-kb clone
is 80-85% homologous to Kd within intron 3 and exons 5-8 and is
-40%o homologous in the 3'-untranslated region. Solid arrows indi-
cate sequencing runs. Broken arrows indicate beginning and ending
of cDNA clones. al, a2, and a3 designations refer to the exons
encoding the three external domains, TM is the transmembrane
domain, and exons 6-8 encode cytoplasmic domains of MHC class
I genes.
located at position 4246 in the fourth intron. PCC4 1.5-kb
differs from C57BL/10 Q7 sequence by -two nucleotides
located at positions 3923 and 4085. These substitutions pre-
sumably correspond to allelic differences between 129/Sv,
C57BL/10, and BALB/c genomes. The PCC4 2.5-kb clone
and the 402AX 2.4-kb clone are almost identical to each other
and are 98-100o homologous to the BALB/c Tla region
"37" gene (ref. 34; Fig. 3B). The only differences between
the "37" gene from a DBA/2 library and the EC clones are
located in the 5' untranslated region just upstream from the
ATG codon of exon 1 (Fig. 4A). The 402AX 2.4-kb and the
PCC4 2.5-kb clones differ from each other only in their length
at the 3' end, where the PCC4 2.5-kb cDNA is four bases
longer than the 402AX 2.4-kb clone (Fig. 3B). The PCC4
3.0-kb cDNA clone does not correspond to any known
sequenced class I gene, although it is highly homologous to
H-2 genes, particularly in the a3 and TM regions where it is
80-90o homologous to several Qa- and Tla-region genes
(Fig. 3C and 4B).
Because cDNA clones from EC cells contained introns, we
used the PCR technique to determine whether EC cells
.,.,,
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Exon 1
271 3'
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.0.TCT...... .. ... ... ... ... ...
.G.TCT...... .. ... ... ... ... ...
B 5 Exon 5
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Kd: GAG CTT CCT CCA TCC ACT GTC TCC AAC ACG GTA ATC ATT GCT GTT CTG GTT GTC CTT GGA
PCC4 ... C. ... ... G.. ... A. ..T T.. T. ..G
...
... ... ... ... ... ... ... ...
3.0: glu pro pro pro ala thr asp ser tyr met val ile ile ala val leu val val leu gly
Kd: GCT GCA ATA OTC ACT GGA GCT GTG GTG GCT TTT GTG ATG AAG ATG AGA AGG AAC ACA G 3'
PCC4 ... .TG ..C A.. A.... ... ... ... ... ... ... ... ... .GA G.G ..A ... ... .
3.0: ala val ile ile ile gly ala val val ala phe val met lys arg gly arg asn thr
FIG. 4. Partial nucleotide sequences of 402AX 2.4-kb and PCC4 2.5-kb cDNA clones and partial nucleotide sequence and deduced amino
acid sequence of PCC4 3.0-kb cDNA clone. The 402AX 2.4-kb and PCC4 2.5-kb clones (A) are compared with the Tla region DBA/2 "37" gene
in the 5' unstranslated region showing the four bases that differ between the EC clones and the "37" gene. The PCC4 3.0-kb cDNA (B) is
compared with the Kd gene for the TM region. A dot at a position indicates identity with the compared sequence.
express fully spliced species of the class I transcripts. Oli-
gonucleotides corresponding to the 5' and 3' ends ofthe "37"
gene were used as primers for the PCR. The presence of the
RNA species was monitored by Southern hybridization of
PCR bands. Hybridization ofthe amplified PCC4 cDNA with
the radiolabeled "37"-specific oligonucleotide shows two
bands (Fig. 5). One band corresponds in size to the partially
spliced PCC4 2.5-kb cDNA and the second band to the fully
processed "37" transcript.
Thus, PCC4 cells transcribe both spliced and unspliced
"37" mRNAs, whereas spleen RNA shows expression of
fully processed "37" transcripts only.
DISCUSSION
EC cells have been used experimentally as a model system
for cellular differentiation, preimplantation development
(37), and tumorigenesis (38). Because of the critical role of
MHC class I antigens in lymphoid cell recognition and their
potential role in cell-cell interactions during embryogenesis,
it is important to determine whether class I molecules are
expressed in EC cells. We have studied the expression of
class I molecules and transcripts in two independently de-
rived EC cell lines. Immunoprecipitation studies and analy-
ses of cDNA libraries demonstrate that 402AX and PCC4
cells express low levels of nonclassical MHC products.
Based on DNA sequence analysis, both cell lines transcribe
the Tla region "37" gene, which has been proposed to encode
an -45-kDa nonpolymorphic cell-surface molecule (10, 39).
The "37" gene is transcribed in a wide variety of cell types
and tissues, including H-2K-, H-2D- brain (10) and 12- to
FIG. 5. PCR on cDNAs synthesized from C57BL/6 spleen and
PCC4 RNAs. The predicted size of the PCR band for fully spliced
"37" mRNA is -1050 bases and for the unspliced band is -2500
bases. The arrows point to PCR bands corresponding to the pre-
sumed fully spliced and unspliced "37" transcripts. A 1-kb A ladder
was used as a size marker.
18-day fetal liver (34). "37" gene transcripts have been
reported not to accumulate in F9 EC cells (34); this result may
reflect differences between F9 and 402AX and PCC4 cells.
Alternatively, the RNase mapping experiments on F9 cells
may have been less sensitive in detecting heterogeneous
species of rare "37" transcripts than the cDNA analyses and
PCR experiments on 402AX and PCC4 cells.
In addition to expressing the "37" gene transcript, PCC4
cells express two other class I transcripts. One of them has
been identified by DNA sequence analysis as the product of
the Q7 gene. The Q7 gene encodes Qa-2 antigens detected on
lymphocytes. These antigens are =40-kDa proteins that are
either attached to the plasma cell membrane by means of a
phospholipid tail (33, 40) or secreted (40). The Q7 gene
displays a complex pattern of expression during develop-
ment. Serological studies suggest the presence of Qa-2 anti-
gens on two-cell-stage mouse embryos (3). Classical H-2
antigens are not detectable until approximately day 11 of
development (1). RNA studies support the serological results
and detect Q7 mRNA in 8.5-day embryos (2). Our identifi-
cation of Q7 transcripts in PCC4 EC cells is consistent with
reports of Q7 expression early in development and further
demonstrates similarities between EC cells and early embry-
onic cells.
The PCC4 3.0-kb clone represents an unidentified class I
gene; its sequence differs from the sequence of all known
class I genes.
All of the isolated EC class I cDNAs correspond to
nonclassical class I products. This finding is consistent with
previous reports showing very low levels or lack of H-2K or
H-2D transcription in EC cells (30, 31) and in early embryos
(41). Our results suggest that Qa/Tla gene transcription is
regulated in EC cells independently of H-2K and H-2D
expression. In contrast to the classical H-2 antigens, nucle-
otide sequences of the regions involved in the transcription
initation of the Q7 and "37" genes lack conventional TATA
boxes. All clones identified in the 402AX and PCC4 libraries
carry some intron sequences. In other studies (42), simian
virus 40-infected EC cells were noted to contain nonspliced
early RNA transcripts. Therefore, it has been proposed that
EC cells regulate expression of certain genes by a posttran-
scriptional mechanism that involves "turning off" of the
specific mRNA-splicing events (42). Qa and Tla transcripts in
EC cells may be partially regulated by a similar mechanism.
If so, then incompletely spliced Qa and Tla transcripts would
coexist with mature, fully spliced RNAs in EC cells. The PCR
experiments demonstrate the presence of unspliced, as well
as mature, "37" mRNAs in PCC4 cells, even though North-
ern analysis failed to detect accumulation ofunspliced RNAs.
This result may be explained by differences in specificity of
the probes used in these two approaches. The absence offully
A
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spliced class I cDNAs is probably the result of the size
selection and/or self-priming second-strand synthesis pro-
cess used in preparation of the cDNAs. Independent of these
considerations, the data are unambiguous in showing tran-
scription of Qa and Tla genes in EC cells.
Immunoprecipitation studies demonstrate that 402AX and
PCC4 cells express low levels of class I-like molecules
associated with 32m. The frequency of class I transcripts in
402AX and PCC4 RNA and in the cDNA libraries correlates
with low-level expression of these class I proteins. It is
unclear whether the class I proteins seen in EC cells are direct
products of the Qa and/or Tla genes identified by cDNA
cloning. More sensitive techniques may be necessary to
identify all transcriptionally active class I genes in PCC4 and
402AX cells and to detect their protein products.
It has recently been hypothesized that T cells expressing
the T-cell antigen receptor y and 8 chains recognize nonclas-
sical MHC class I antigens (4-6). This hypothesis suggests
that the Qa and/or Tla gene products identified in this study
may serve as the target structure(s) for T-cell recognition of
the 402AX and/or PCC4 cells. Additi6nal studies are neces-
sary to determine whether "37", Q7, or other class I mole-
cules are present in sufficient quantity on the cell surface of
EC cells and whether these class I genes encode antigens
involved in T-cell-mediated antitumor immunity.
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